Industry Outlook

Phospholipase enzyme market is projected to reach 7.0% CAGR during the forecast period from 2024 to 2032. In 2021, North America held the largest value share in the global phospholipase enzyme market. Asia Pacific is projected to be the fastest-growing region between 2023 and 2032.

Phospholipases are enzymes that basically hydrolyze phospholipids thereby separating the polar and a fatty acid which is one of the hydrophobic portions of phospholipid molecule. These are mainly found in tissues and pancreatic secretions.

Increasing application in food and beverages is one of the primary factor expected to boost the demand for phospholipase enzymes. Owing to this fact, key players such as Novozymes A/S, AB Enzymes GmbH and DowDuPont Inc.  are investing in the food and beverages market due to growing demand for phospholipase enzymes from such industries. Increasing awareness regarding the health benefits of phospholipase enzymes is expected to drive the global market. They play an important role in venoms and toxins in digesting membranes that aims to allow the spread of infection. In addition to digestive function in various recycling precursors, they also have various roles in signal transduction. Increasing incidence of digestive diseases and disorders is also propelling the growth of this market. As per Florida Hospital based in the U.S, a quarter of cancer deaths in the U.S are due to gastrointestinal cancers. Unhealthy eating patterns in developed regions that includes North America and Europe have led to the dependency on various digestive enzyme supplements which in turn is expected to accelerate the demand for enzymes thereby augmenting the market demand for phospholipase enzymes. Various common digestive disorders that includes IBS (irritable bowel syndrome) can be treated by using lipases. The reason being lipase mainly finds application in exocrine pancreatic insufficiency treatment. In addition, phospholipase enzymes along with lipase can be used in the treatment of obesity which is one of the important health concern in developed countries. Phospholipase enzymes also plays an important role in signal transduction, membrane trafficking, apoptosis and cell proliferation in pharmaceuticals industry. Hence, owing to its growing application in pharmaceuticals industry, the demand for phospholipase enzymes is expected to rise during the forecast period from 2023 to 2030. Phospholipase enzymes also plays a key role in biodiesel production as a biocatalyst. According to the UN's Food and Agriculture Organization (FAO) and Organization for Economic Cooperation and Development(OECD), the global biodiesel consumption and production is forecast to rise by 14% from 2023 to 2030.This is mainly driven by the fulfillment of various biofuel policies in Argentina, U.S, Brazil, the EU and Indonesia. Hence, with the increase in biodiesel production, worldwide, the demand for phospholipase enzymes is projected to rise during the forecast period from 2023 to 2030.

"Phospholipase A2 (PLA2) is the Largest Segment by Product Type in The Global Phospholipase Enzyme market"

PLA2 is basically defined as a lipolytic enzyme which catalyzes hydrolysis of sn-2 ester bond into various forms of phospholipids. It is essential to immune response and inflammation. Secretory PLA2 family, where 10 isozymes are identified mainly consists of Ca2+-requiring, low-molecular-weight and secretory enzymes which finds application in various biological processes that includes modification of inflammation, atherosclerosis, eicosanoid generation and host defense among others. Cytosolic PLA2 plays an important role in AA metabolism initiation. The primary use of phospholipase A2 enzyme is to increase the efficacy of various phospholipids, that mainly includes lecithin. It is also used as an emulsifier in various aqueous food products, such as sauces, bakery products and dressings. Phospholipase A2 enzyme derived from porcine pancreas also acts as a processing aid. The key role of PLA2 in cancer and various inflammatory related disorders makes this type of enzyme a very potential target for various drug development. It also finds application as a potential therapy for various inflammatory skin diseases that includes autoimmune diseases, allergies and ulcers among others. Trend shows that PLA2 is also used as a therapeutic target for atherosclerosis. For example, in November 2016, Technopath Clinical Diagnostics (TCD) launched the i-plaq test which is a CE marked diagnostic reagent kit. This is basically a blood test that enables the clinicians to detect Lp-PLA2, with an objective to assess the risk of both ischemic stroke and coronary heart disease that are associated with atherosclerosis. All these factors are expected to drive the demand for PLA2 in the global phospholipase enzyme market.

"Microbial is the Largest Segment by Source in The Global Phospholipase Enzyme market"

Growing applications of microorganisms in food fermentation is expected to propel the demand for phospholipase enzyme market. They are mainly used in food and beverages industries owing to the fact that these can be produced through cost effective fermentation techniques with less space requirement and time because of their process modification, high consistency and easy optimization. Increasing application of microorganisms in various industrial applications that includes detergent, textile, food and paper is also projected to drive the market demand during the forecast period from 2023 to 2030. They are also used for the production of crystalline glucose, glucose syrups, maltose syrups and high fructose corn syrups. In detergent industry, microorganisms are basically used as additives to remove various starch based strains. Growing application of amylases in textile industry especially for warp sizing of various textile fibers is expected to augment the market growth. In paper industry, they are also used for starch viscosity reduction for appropriate paper coating. In addition, wide applications of various microorganisms that includes lipases, proteases and xylanases in food industry is projected to boost the market demand. Companies are focusing on expanding their microbial business segment to cater to the growing demand for phospholipase enzyme across various industries.

"Food and Beverages Segment Driving the Growth of Phospholipase Enzyme market"

Increasing application of phospholipase enzyme in dairy, bakery, flavors and emulsifiers is expected to propel the demand for food and beverages segment in the global phospholipase enzyme market. Increasing application of PLA2 in emulsions (sauces and dressings), baked goods (cakes and breads) and hydrolyzed lecithin production (soybean, rapeseed or sunflower) is expected to boost the global market. Phospholipase enzymes aims to improve the heat stability and also enhances mouthfeel and viscosity of sauces and dressings. It also increases the emulsifying property of whole eggs or egg yolks. In addition, phospholipase enzymes also aid in extending the shelf-life followed by improving the softness and crumb structure of baked goods. Increasing demand for processed food is another factor expected to drive the market growth. Phospholipase enzymes also plays an important role in cheese production. In cheese production, lysophospholipids basically act as a surface-active agent in cheese curds, thereby helping emulsification of fat and water during processing. It also helps in reducing syneresis.

"Liquid is the Largest Segment by Form in The Global Phospholipase Enzyme market"

Liquid phospholipase enzyme mainly used for hydrolyzing phospholipids to lyso-phospholipids in various vegetable oils from rape/canola, soy, sunflower, mustard and cotton seeds, rice bran, groundnuts and corn at a low pH. Growing application in vegetable processing is expected to drive the demand for this segment. ROHALASE® PL-XTRA, a liquid formulated fungal PL2, offered by AB enzymes permits enzyme-assisted degumming and also aims to minimize scale build up in various processing equipment thereby reducing maintenance downtime. Increasing application in detergents followed by little storage space are other factors expected to augment the demand for this segment. The liquid segment is also expected to grow at a fastest rate during the forecast period from 2023 to 2030.

"North America is the Largest Region in the Global Phospholipase Enzyme market"

Globally, North America accounted for the largest share of phospholipase enzyme market. The U.S is the key country in the North America phospholipase enzyme market. The growth is mainly attributed to the growing demand for phospholipase enzyme in food and beverages industry especially baked goods and dairy products. Increasing awareness among consumers related to the health benefits of phospholipase enzyme is also expected to propel the growth of this market during the forecast period from 2023 to 2030.Growing industrial applications of phospholipase enzyme is also expected to propel the market growth. Trend shows that owing to unhealthy eating patterns, there has been increasing incidence of digestive diseases and disorders. This in turn is expected to propel the demand for various digestive supplements thereby accelerating the demand for phospholipase enzyme in North America. Digestive health is one of the fastest growing markets in the U.S, followed by bone health, heart health, immune health markets and weight management. Manufacturers are also focusing on introducing various digestive health and gut health products, which clearly indicates consumer preference for healthy diet. Asia Pacific is expected to grow at a fastest rate owing to growing demand for processed foods. Increasing application in various end user industries that includes brewing, cheese processing, baking, fruit juice processing and meat processing among others is also expected to drive the demand for phospholipase enzyme in Asia Pacific region.

"Merger and Acquisition is one of the Key Strategies Adopted by the Manufacturers"

Key players operating in the global phospholipase enzyme market includes Koninklijke DSM N.V., Bioseutica B.V., Enzo Life Sciences Inc, EUCODIS Bioscience GmbH, Sanyo Fine Co. Ltd., Novozymes A/S, Chr. Hansen Holding A/S, AB Enzymes GmbH, DowDuPont Inc., Genetrix Ingredients, Aumgene Biosciences and Nagase America Corporation among others. For example, in September 2016, Novozymes, based in Denmark, acquired Organobalance GmbH, a microbial research company based in Germany, with an objective to strengthen its position in delivering sustainable and new microbial solutions.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Phospholipase Enzyme market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Phospholipase Enzyme market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Phospholipase Enzyme market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Phospholipase Enzyme market?
• Which is the largest regional market for Phospholipase Enzyme market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Phospholipase Enzyme market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Phospholipase Enzyme market worldwide?